- Home
- FAF vs RVMD Comparison
FAF vs RVMD Comparison
Compare FAF & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAF
- RVMD
- Stock Information
- Founded
- FAF 1889
- RVMD 2014
- Country
- FAF United States
- RVMD United States
- Employees
- FAF N/A
- RVMD N/A
- Industry
- FAF Specialty Insurers
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FAF Finance
- RVMD Health Care
- Exchange
- FAF Nasdaq
- RVMD Nasdaq
- Market Cap
- FAF 6.8B
- RVMD 7.5B
- IPO Year
- FAF N/A
- RVMD 2020
- Fundamental
- Price
- FAF $64.37
- RVMD $46.71
- Analyst Decision
- FAF Buy
- RVMD Strong Buy
- Analyst Count
- FAF 4
- RVMD 15
- Target Price
- FAF $75.00
- RVMD $74.47
- AVG Volume (30 Days)
- FAF 731.1K
- RVMD 2.3M
- Earning Date
- FAF 10-22-2025
- RVMD 11-05-2025
- Dividend Yield
- FAF 3.39%
- RVMD N/A
- EPS Growth
- FAF N/A
- RVMD N/A
- EPS
- FAF 1.82
- RVMD N/A
- Revenue
- FAF $6,514,800,000.00
- RVMD N/A
- Revenue This Year
- FAF $17.77
- RVMD N/A
- Revenue Next Year
- FAF $8.54
- RVMD $454.11
- P/E Ratio
- FAF $35.12
- RVMD N/A
- Revenue Growth
- FAF 9.54
- RVMD N/A
- 52 Week Low
- FAF $53.09
- RVMD $29.17
- 52 Week High
- FAF $70.92
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- FAF 46.32
- RVMD 63.96
- Support Level
- FAF $62.72
- RVMD $45.61
- Resistance Level
- FAF $64.72
- RVMD $47.08
- Average True Range (ATR)
- FAF 1.12
- RVMD 1.60
- MACD
- FAF -0.36
- RVMD 0.02
- Stochastic Oscillator
- FAF 31.98
- RVMD 83.73
About FAF First American Corporation (New)
First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.